Synopsis of recent research by authors named "Shahla Bari"
- Shahla Bari's recent research primarily focuses on the application and efficacy of immune checkpoint inhibitors in geriatric oncology, emphasizing the need for tailored approaches and insights into outcomes for older patients due to underrepresentation in clinical trials.
- Her studies also examine the real-world effectiveness and side effects of targeted therapies, such as alpelisib for metastatic breast cancer, highlighting the necessity for better understanding how these treatments perform in diverse patient populations.
- Additionally, Bari explores the impact of the gut microbiome on immunotherapy responses in lung cancer, and the importance of addressing chemotherapy-induced nausea, revealing the multifaceted challenges in treating various cancer types effectively.
